‌ 

2019 Accepted Abstracts

Please note that abstracts have not been edited by CMHC staff for content, style, or accuracy, and are displayed as input by each submitter.

001Assessing the Impact of Switching to the Tobacco Heating System on Cardiovascular Events: Translating Basic Science Into Clinical Benefit.

Friday, October 11, 2019, 10:15 – 11:15 AM, 2:25 - 3:25 PM

Saturday, October 12, 2019, 10:00 – 11:00 AM, 2:15 – 3:15 PM

Pater C, Haziza C, Elamin A, Pouly S, de La Bourdonnaye G, Tran CT, Blanc N, van der Plas A, Heremans A

Philip Morris International

003Omental Adipose Removal Decreases High Blood Pressure in Hypertensive Patients Independent of Body Mass Index.

Friday, October 11, 2019, 10:15 – 11:15 AM, 2:25 - 3:25 PM

Saturday, October 12, 2019, 10:00 – 11:00 AM, 2:15 – 3:15 PM

Jiang L1, Sun W1, Zhang M2, Wang Y1, Tian Y2, Li P2, Lu Y2, Xu T1, Qiu M3, Yang Y3, Jia X3, Zhou B2, Kong X1

1. Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; 2. Department of Pediatrics, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; 3. Department of Gynecological Tumor, Nanjing Maternity and Child Health Hospital, Nanjing, Jiangsu, China.

005Does Depressed Persons with Non-Cardiovascular Morbidity Have a Higher Risk of CVD? A Population-Based Cohort Study in Sweden.

Friday, October 11, 2019, 10:15 – 11:15 AM, 2:25 - 3:25 PM

Saturday, October 12, 2019, 10:00 – 11:00 AM, 2:15 – 3:15 PM

Almas A1,2, Moller J1, Iqbal R3, Lundin A1, Forsell Y1

1. Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden; 2. Department of Medicine, Aga Khan University, Karachi, Pakistan; 3. Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan

006Role of Triglyceride Monitoring in Patients with Familial Chylomicronemia Syndrome.

Friday, October 11, 2019, 10:15 – 11:15 AM, 2:25 - 3:25 PM

Saturday, October 12, 2019, 10:00 – 11:00 AM, 2:15 – 3:15 PM

Priedane E1, Juniat S1, Philips GA2, Hurst S2, Soran H3, Davidson M4, Rosenson RS5

1. Huron Consulting Group, Chicago, IL; 2. Akcea Therapeutics, Boston, MA; 3. Central Manchester University Hospital NHS Foundation Trust, Manchester, UK; 4. Department of Medicine, University of Chicago, Chicago, IL; 5. School of Medicine at Mount Sinai, New York, NY.

007STEMIs with Elder Age May Fare Similar to Young age –An Unexpected Result.

Friday, October 11, 2019, 10:15 – 11:15 AM, 2:25 - 3:25 PM

Saturday, October 12, 2019, 10:00 – 11:00 AM, 2:15 – 3:15 PM

Iqbal SR1, Almas A2, Khan AH3

1. MBBS, Resident level III, Adult Cardiology, Department of Medicine Aga Khan University Hospital, Karachi, Pakistan; 2. MBBS, FCPS (Internal Medicine), FACC, Associate Professor, Cardiology, Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan; 3. MBBS, FCPS (Medicine and Cardiology) Professor, Cardiology, Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.

008Coronary Lesions in Young South Asians -A High Risk Population.

Friday, October 11, 2019, 10:15 – 11:15 AM, 2:25 - 3:25 PM

Saturday, October 12, 2019, 10:00 – 11:00 AM, 2:15 – 3:15 PM

Iqbal SR1, Almas A2, Khan AH3

1. MBBS, Resident level III, Adult Cardiology, Department of Medicine Aga Khan University Hospital, Karachi, Pakistan; 2. MBBS, FCPS (Internal Medicine), FACC, Associate Professor, Cardiology, Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan; 3. MBBS, FCPS (Medicine and Cardiology) Professor, Cardiology, Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.

009IDegLira Improves Glycemic Control in People with Type 2 Diabetes Uncontrolled on Basal Insulin Without Deterioration Despite Discontinuing Pre-trial Sulfonylurea.

Friday, October 11, 2019, 10:15 – 11:15 AM, 2:25 - 3:25 PM

Saturday, October 12, 2019, 10:00 – 11:00 AM, 2:15 – 3:15 PM

Salvesen-Sykes K1, Janez A2, Silver R3, Vilsbøll T4, Grøn R5, Halladin N5, ┼Érsy P5, Harris S6

1. Novo Nordisk Inc., Plainsboro, NJ; 2. Ljubljana University Medical Centre, Ljubljana, Slovenia; 3. Southern New Hampshire Medical Center, Nashua, NH; 4. Steno Diabetes Center, University of Copenhagen, Copenhagen, Denmark; 5. Novo Nordisk A/S, Søborg, Denmark; 6. Western University, London, ON, Canada.

012Effect of Patiromer in Patients 75 Years or Older with Diabetic Kidney Disease and Hyperkalemia Receiving a RAAS Inhibitor

Friday, October 11, 2019, 10:15 – 11:15 AM, 2:25 - 3:25 PM

Saturday, October 12, 2019, 10:00 – 11:00 AM, 2:15 – 3:15 PM

Bakris GL1, Woods SD2, Alvarez PJ2, Fogli J2, Arthur S2, Mayo MR2, Kumar R3

1. University of Chicago Medical Center, Chicago, IL; 2. Relypsa, Inc., a Vifor Pharma Group Company, Redwood City, CA; 3. Midwest Geriatrics, Burr Ridge, IL.

013Soluble ST2 is Directly Correlated with HbA1c in Individuals With an Average Glycaemia In the Normal/Prediabetes Range

Friday, October 11, 2019, 10:15 – 11:15 AM, 2:25 - 3:25 PM

Saturday, October 12, 2019, 10:00 – 11:00 AM, 2:15 – 3:15 PM

Hasan A1, Al Dahi W2

1. Dasman Diabetes Institute, Dasman, Kuwait; 2. Ministry of Health, Kuwait City, Kuwait

014Effectiveness and Safety of Apixaban, Dabigatran and Rivaroxaban versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation: ARISTOPHANES Subgroup Analysis

Friday, October 11, 2019, 10:15 – 11:15 AM, 2:25 - 3:25 PM

Saturday, October 12, 2019, 10:00 – 11:00 AM, 2:15 – 3:15 PM

Deitelzweig S1, Keshishian A2,3, Kang A4, Dhamane A4, Luo X5, Li X4, Balachander N4, Rosenblatt L4, Mardekian J6, Pan X4, Di Fusco M6, Garcia AB4,7, Yuce H3, Lip GYH8

1. Ochsner Clinic Foundation, Department of Hospital Medicine, New Orleans, LA, USA and The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA; 2. STATinMED Research, Ann Arbor, MI; 3. New York City College of Technology, City University of New York, New York, NY; 4. Bristol-Myers Squibb Company, Lawrenceville, NJ; 5. Pfizer, Inc., Groton, CT; 6. Pfizer, Inc., New York, NY; 7. University of North Carolina, Chapel Hill, NC; 8. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

016Relationship Between Biochemical Parameters, Oxidative Stress Markers and Glycemic Control in Type II Diabetes Mellitus

Friday, October 11, 2019, 10:15 – 11:15 AM, 2:25 - 3:25 PM

Saturday, October 12, 2019, 10:00 – 11:00 AM, 2:15 – 3:15 PM

Fagbohun OF1, Odewole TO2, Emma-Okon BO3, Agboola FK2, Kolawole BA4, Onakpoya OH5

1. Department of Biomedical Engineering, First Technical University, Ibadan, Oyo State, Nigeria; 2. Department of Biochemistry, Obafemi Awolowo University (OAU), Ile-Ife, Osun State, Nigeria; 3. Department of Medical Biochemistry, Obafemi Awolowo University (OAU), Osun State, Nigeria; 4. Department of Medicine, Obafemi Awolowo University (OAU), Ile-Ife, Osun State, Nigeria; 5. Department of Surgery (Ophthalmology Unit), Obafemi Awolowo University (OAU), Ile-Ife, Osun State, Nigeria.

017Endothelin-1 Gene Polymorphisms in Severe Pulmonary Hypertension Associated with Rheumatic Mitral Stenosis

Friday, October 11, 2019, 10:15 – 11:15 AM, 2:25 - 3:25 PM

Saturday, October 12, 2019, 10:00 – 11:00 AM, 2:15 – 3:15 PM

Mehra P, Mehta V, Yusuf J, Mukhopadhyay S, Tyagi S

G. B. Pant Institute of Postgraduate Medical Education & Research, New Delhi, India

018Correlation of IL-6, IL-10, IL-18 and TNF-α Levels with Severity of Rheumatic Mitral Stenosis and Secondary Pulmonary Hypertension

Friday, October 11, 2019, 10:15 – 11:15 AM, 2:25 - 3:25 PM

Saturday, October 12, 2019, 10:00 – 11:00 AM, 2:15 – 3:15 PM

Mehta V, Mehra P, Tripathi G, Yusuf J, Mahajan B, Tyagi S

G. B. Pant Institute of Postgraduate Medical Education & Research, New Delhi, India

019Can Activity Monitoring and Connected Health Increase Physical Activity in Patients with Obesity? A Pilot Study

Friday, October 11, 2019, 10:15 – 11:15 AM, 2:25 - 3:25 PM

Saturday, October 12, 2019, 10:00 – 11:00 AM, 2:15 – 3:15 PM

Katayama M1, Paul F1, Scales R1, Buras M1, Lim E1, Bersoux S1, Chaliki H2, Cataldo D3, Fernandes RI2

1. Mayo Clinic, Scottsdale, AZ; 2. Mayo Clinic, Phoenix, AZ; 3. Arizona State University, Phoenix, AZ